The management and prognosis of breast cancer are largely determined by the expression status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) of the tumor [2]–[4]. The gene discussed is ERBB2; the disease is breast carcinoma.